- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
U.S. Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Results
4
1 new
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
TLRY | US$1.26 | 5.9% | -42.5% | US$1.1b | US$2.18 | PS1.4x | E71.6% | n/a | ||
MRVI | US$5.37 | -5.3% | -18.8% | US$1.4b | US$9.07 | PS2.8x | E84.7% | n/a | ||
SNDL New | US$1.80 | 1.1% | 16.9% | US$477.9m | US$3.19 | PS0.8x | E144.4% | n/a | ||
TYRA | US$14.00 | -6.3% | 4.1% | US$736.4m | US$31.00 | PB2x | E-4.5% | n/a |
Page 1 of 1